A PENNdemic Year in Review

  • Sarah E. Herlihy
    Corresponding author.
    Department of Pathology and Laboratory Medicine, Molecular Pathology Laboratory, Hospital of the University of Pennsylvania, 7 Maloney Building, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Search for articles by this author
  • Caren Gentile
    Department of Pathology and Laboratory Medicine, Molecular Pathology Laboratory, Hospital of the University of Pennsylvania, 7 Maloney Building, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Search for articles by this author
Published:September 01, 2021DOI:https://doi.org/10.1016/j.yamp.2021.06.007
      A dedicated clinical development team is advantageous and allows flexibility during an emergency so that clinical work can continue uninterrupted.


      To read this article in full you will need to make a payment


      Subscribe to Advances in Molecular Pathology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dong E.
        • Du H.
        • Gardner L.
        An interactive web-based dashboard to track COVID-19 in real time.
        Lancet Infect Dis. 2020; 20: 533-534
      1. COVID-19 in Pennsylvania. Pennsylvania Department of Health, 2021 (Available at:) (Accessed April 9, 2021)
      2. Coronavirus disease 2019 (COVID-19): providing information and updates about COVID-19 in Philadelphia. Philadelphia Department of Health, 2021 (Available at:) (Accessed April 9, 2021)
      3. Opening remarks at the media briefing on COVID19 [press release]. 2021 (Available at:)
        • Giorgi G.
        • Lecca L.I.
        • Alessio F.
        • et al.
        COVID-19-related mental health effects in the workplace: a narrative review.
        Int J Environ Res Public Health. 2020; 17: 7857
        • Wu K.L.
        ‘Nobody sees us’: testing-lab workers strain under demand.
        (Available at:) (Accessed April 8, 2021)
      4. Association for Molecular Pathology SARS-CoV-2 molecular testing: summary of August SARS-CoV-2 molecular testing survey. Association for Molecular Pathology, 2020 (Available at:)
      5. Association for Molecular Pathology SARS-CoV-2 Molecular Testing: Summary of April SARS-CoV-2 Molecular Testing Survey. Association for Molecular Pathology;2020.

      6. Gentile C, Richard-Greenblatt, M, Fink, J, et al. A practical comparison of seven molecular SARS-CoV-2 methods paper presented at: Association for Molecular Pathology Annual Meeting November 16-20, 2020.

        • Wrighton M.S.
        • Lawrence S.J.
        Reopening colleges and universities during the COVID-19 pandemic.
        Ann Intern Med. 2020; 173: 664-665
        • Odriozola-Gonzalez P.
        • Planchuelo-Gomez A.
        • Irurtia M.J.
        • et al.
        Psychological effects of the COVID-19 outbreak and lockdown among students and workers of a Spanish university.
        Psychiatry Res. 2020; 290: 113108
        • Dhar B.K.
        • Ayittey F.K.
        • Sarkar S.M.
        Impact of COVID-19 on psychology among the university students.
        Glob Chall. 2020; 4: 2000038
        • Paltiel A.D.
        • Zheng A.
        • Walensky R.P.
        Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States.
        JAMA Netw Open. 2020; 3: e2016818
        • Tanabe K.O.
        • Hayden M.E.
        • Zunder B.
        • et al.
        Identifying vulnerable populations at a university during the COVID-19 pandemic.
        J Am Coll Health. 2021; : 1-4
        • Van Pelt A.
        • Glick H.A.
        • Yang W.
        • et al.
        Evaluation of COVID-19 testing strategies for repopulating college and university campuses: a decision tree analysis.
        J Adolesc Health. 2021; 68: 28-34
      7. Overview of testing for SARS-CoV-2 (COVID-19). Centers for Disease Control and Prevention, 2021 (Available at:) (Accessed March 25, 2021)
      8. Screening for COVID-19: deciding which test to use when establishing testing programs. U.S. Food and Drug Administration, 2021 (Available at:) (Accessed March 25, 2021)
        • Ryan B.J.
        • Muehlenbein M.P.
        • Allen J.
        • et al.
        Sustaining university operations during the COVID-19 pandemic.
        Disaster Med Public Health Prep. 2021; : 1-24
      9. COVID-19 dashboard. University of Pennsylvania, 2021 (Available at:) (Accessed 2021)
      10. West Philadelphia Skills Initiative. 2021 (Available at:) (Accessed April 7, 2021)
        • CDC OneLab
        Division of laboratory systems.
        2021 (Available at:) (Accessed April 7, 2021)
        • Meredith L.W.
        • Hamilton W.L.
        • Warne B.
        • et al.
        Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
        Lancet Infect Dis. 2020; 20: 1263-1271
      11. CLIA SARS-CoV-2 variant testing frequently asked question.
        (Available at:) (Accessed April 5, 2021)
        • Harilal D.
        • Ramaswamy S.
        • Loney T.
        • et al.
        SARS-CoV-2 whole genome amplification and sequencing for effective population-based surveillance and control of viral transmission.
        Clin Chem. 2020; 66: 1450-1458
        • Behrmann O.
        • Spiegel M.
        COVID-19: from rapid genome sequencing to fast decisions.
        Lancet Infect Dis. 2020; 20: 1218
      12. Emergency Use Authorization. 2021 (Available at:) (Accessed April 8, 2021)
      13. SARS-CoV-2 viral mutations: impact on COVID-19 tests. 2021 (Available at:) (Accessed June 8, 2021)
        • Artesi M.
        • Bontems S.
        • Gobbels P.
        • et al.
        A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the e gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay.
        J Clin Microbiol. 2020; 58: e01598
        • Staff B.T.B.
        Thermo Fisher’s COVID-19 tests: designed with virus mutations in mind. vol. 2021. 2020 (Available at:)
        • Hasan M.R.
        • Sundararaju S.
        • Manickam C.
        • et al.
        A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by reverse transcription-quantitative PCR.
        J Clin Microbiol. 2021; 59: e03278
      14. FDA authorizes revisions to fact sheets to address SARS-CoV-2 variants for monoclonal antibody products under Emergency Use Authorization. 2021 (Available at:) (Accessed June 8, 2021)
        • Taylor P.C.
        • Adams A.C.
        • Hufford M.M.
        • et al.
        Neutralizing monoclonal antibodies for treatment of COVID-19.
        Nat Rev Immunol. 2021; 21: 382-393
        • Tada T.
        • Dcosta B.M.
        • Zhou H.
        • et al.
        Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies.
        bioRxiv. 2021;
        • Volz E.
        • Mishra S.
        • Chand M.
        • et al.
        Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
        Nature. 2021;
        • Callaway E.
        Multitude of coronavirus variants found in the US - but the threat is unclear.
        Nature. 2021; 591: 190
        • Deng X.
        • Garcia-Knight M.A.
        • Khalid M.M.
        • et al.
        Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation.
        medRxiv. 2021;
        • Annavajhala M.K.
        • Mohri H.
        • Zucker J.E.
        • et al.
        A novel SARS-CoV-2 variant of concern, B.1.526, identified in New York.
        medRxiv. 2021;
        • Furuse Y.
        Genomic sequencing effort for SARS-CoV-2 by country during the pandemic.
        Int J Infect Dis. 2021; 103: 305-307
        • Domingo E.
        • Perales C.
        The time for COVID-19 vaccination.
        J Virol. 2021;
        • Kennedy D.A.
        • Read A.F.
        Monitor for COVID-19 vaccine resistance evolution during clinical trials.
        PLoS Biol. 2020; 18: e3001000
        • Wadman M.
        United States rushes to fill void in viral sequencing.
        Science. 2021; 371: 657-658
      15. UNC surveillance report. UNC Contributing labs. 2021 (Available at:) (Accessed April 8, 2021)
      16. Genomic surveillance for SARS-CoV-2 variants. National Center for Immunization and Respiratory Diseases (NCIRD), division of viral diseases.
        (Available at:) (Accessed April 8, 2021)